RPS2P48

Across TCGA pan-cancer cohorts, RPS2P48 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of RPS2P48’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RPS2P48 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS2P48 is over-expressed in tumor.

KIRP, COAD, and KIRC are the cancer types where RPS2P48 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS2P48 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	III,IV	+0.297	<.001	11	view →
COAD	Female	All	+1.274	<.001	10	view →
KIRC	Male	All	+0.269	<.001	10	view →
LUSC	Male	All	+0.264	<.001	7	view →
LIHC	All	All	+0.107	<.001	5	view →
LUAD	All	All	+0.184	.003	3	view →
UCEC	All	All	+0.562	.006	2	view →
READ	All	All	+0.428	.003	2	view →
CHOL	Female	All	+0.190	.015	2	view →
KICH	All	II,III,IV	+0.187	.014	2	view →
PRAD	All	All	+0.164	.016	2	view →
HNSC	Male	All	+0.135	.025	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

RPS2P48–KIRP

Open the KIRP breakdown →